首页 > 最新文献

Annals of Saudi Medicine最新文献

英文 中文
Efficacy of bedside optic nerve sheath diameter measurement in differentiating provoked seizure from unprovoked seizure in the emergency department. 床边视神经鞘直径测量在急诊科鉴别诱发性癫痫与非诱发性癫痫的疗效。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-01-01 DOI: 10.5144/0256-4947.2023.42
Fevzi Yılmaz, Bedriye Muge Sonmez, Cemil Kavalci, Engin Deniz Arslan, Gulsum Caliskan, Inan Beydilli

Background: Emergency departments (EDs) are typically the first medical contact for seizure patients, and early diagnosis and treatment is primarily the responsibility of emergency physicians.

Objectives: Demonstrate the efficacy of bedside ocular ultrasonography for optic nerve sheath diameter (ONSD) measurement in differentiating provoked seizure from unprovoked seizure in the ED.

Design: Prospective observational study SETTINGS: Tertiary care hospital PATIENTS AND METHODS: Patients presenting to the ED with seizure were divided into two groups according to medical history, physical examination, laboratory results, cranial computed tomography findings and electroencephalography results. Patients with seizures that did not have a specific cause (unprovoked) were compared with patients who had seizures caused by underlying pathology (provoked). The measurement of the ONSD was taken at the bedside within 30 minutes of arrival. The study compared the ONSD values, age, sex, type of seizure, and Glasgow Coma Score between the two groups.

Main outcome measure: Efficacy of ONSD to distinguish between provoked and unprovoked seizures.

Sample size: 210 patients RESULTS: One hundred and fourteen (54.3%) patients were in the provoked seizure group and 96 (45.7%) were in the unprovoked seizure group. The ONSD measurements were significantly higher in the provoked seizure group compared with the unprovoked seizure group (median 6.1 mm vs. 5.2 mm, P<.001). The cut-off value of ONSD higher than 5.61 was significantly associated with the prediction of the provoked seizure (P<.001). The area under the curve value was 0.882 (95% CI: 0.830-0.922) with a sensitivity of 86.5 and specificity of 78.9%.

Conclusions: Bedside ONSD measurement by means of ocular ultrasound is an effective method for differentiating provoked seizure from unprovoked seizure.

Limitations: Statistical significance of age on ONSD and exclusion of pediatric patients.

Conflict of interest: None.

背景:急诊科(EDs)通常是癫痫患者的第一个医疗接触,早期诊断和治疗是急诊医生的主要责任。目的:证明床边眼超声测量视神经鞘直径(ONSD)在鉴别ed诱发性癫痫发作和非诱发性癫痫发作中的作用。设计:前瞻性观察研究设置:三级医院患者和方法:根据病史、体格检查、实验室检查结果、颅脑ct及脑电图结果将出现癫痫发作的ED患者分为两组。没有特定原因(非诱发)的癫痫发作患者与由潜在病理(诱发)引起的癫痫发作患者进行比较。在患者到达后30分钟内在床边测量ONSD。该研究比较了两组患者的ONSD值、年龄、性别、癫痫发作类型和格拉斯哥昏迷评分。主要结局指标:ONSD区分诱发性和非诱发性癫痫发作的疗效。结果:诱发性癫痫发作组114例(54.3%),非诱发性癫痫发作组96例(45.7%)。诱发性癫痫发作组的ONSD测量值明显高于非诱发性癫痫发作组(中位值6.1 mm vs. 5.2 mm, ppp)。结论:通过眼超声床边ONSD测量是鉴别诱发性癫痫发作与非诱发性癫痫发作的有效方法。局限性:年龄对ONSD有统计学意义,排除儿科患者。利益冲突:无。
{"title":"Efficacy of bedside optic nerve sheath diameter measurement in differentiating provoked seizure from unprovoked seizure in the emergency department.","authors":"Fevzi Yılmaz,&nbsp;Bedriye Muge Sonmez,&nbsp;Cemil Kavalci,&nbsp;Engin Deniz Arslan,&nbsp;Gulsum Caliskan,&nbsp;Inan Beydilli","doi":"10.5144/0256-4947.2023.42","DOIUrl":"https://doi.org/10.5144/0256-4947.2023.42","url":null,"abstract":"<p><strong>Background: </strong>Emergency departments (EDs) are typically the first medical contact for seizure patients, and early diagnosis and treatment is primarily the responsibility of emergency physicians.</p><p><strong>Objectives: </strong>Demonstrate the efficacy of bedside ocular ultrasonography for optic nerve sheath diameter (ONSD) measurement in differentiating provoked seizure from unprovoked seizure in the ED.</p><p><strong>Design: </strong>Prospective observational study SETTINGS: Tertiary care hospital PATIENTS AND METHODS: Patients presenting to the ED with seizure were divided into two groups according to medical history, physical examination, laboratory results, cranial computed tomography findings and electroencephalography results. Patients with seizures that did not have a specific cause (unprovoked) were compared with patients who had seizures caused by underlying pathology (provoked). The measurement of the ONSD was taken at the bedside within 30 minutes of arrival. The study compared the ONSD values, age, sex, type of seizure, and Glasgow Coma Score between the two groups.</p><p><strong>Main outcome measure: </strong>Efficacy of ONSD to distinguish between provoked and unprovoked seizures.</p><p><strong>Sample size: </strong>210 patients RESULTS: One hundred and fourteen (54.3%) patients were in the provoked seizure group and 96 (45.7%) were in the unprovoked seizure group. The ONSD measurements were significantly higher in the provoked seizure group compared with the unprovoked seizure group (median 6.1 mm vs. 5.2 mm, <i>P</i><.001). The cut-off value of ONSD higher than 5.61 was significantly associated with the prediction of the provoked seizure (<i>P</i><.001). The area under the curve value was 0.882 (95% CI: 0.830-0.922) with a sensitivity of 86.5 and specificity of 78.9%.</p><p><strong>Conclusions: </strong>Bedside ONSD measurement by means of ocular ultrasound is an effective method for differentiating provoked seizure from unprovoked seizure.</p><p><strong>Limitations: </strong>Statistical significance of age on ONSD and exclusion of pediatric patients.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"43 1","pages":"42-49"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/55/0256-4947.2023.42.PMC9899342.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9619236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of critically ill obstetric patients treated in an intensive care unit during the COVID-19 pandemic. COVID-19大流行期间重症监护病房重症产科患者的评估
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-01-01 DOI: 10.5144/0256-4947.2023.10
Kadir Arslan, Hale Çetin Arslan, Ayca Sultan Şahin

Background: Although obstetric morbidity and mortality have decreased recently, rates are still high enough to constitute a significant health problem. With the COVID-19 pandemic, many obstetric patients have required treatment in intensive care units (ICU).

Objectives: Evaluate critical obstetric patients who were treated in an ICU for COVID-19 and followed up for 90 days.

Design: Medical record review SETTING: Intensıve care unit PATİENTS AND METHODS: Obstetric patients admitted to the ICU between 15 March 2020 and 15 March 2022 and followed up for at least 90 days were evaluated retrospectively. Patients with and without COVID-19 were compared by gestational week, indications, comorbidities, length of stay in the hospital and ICU, requirement for mechanical ventilation, blood transfusion, renal replacement therapy (RRT), plasmapheresis, ICU scores, and mortality.

Main outcome measures: Clinical outcomes and mortality.

Sample size and characteristics: 102 patients with a mean (SD) maternal age of 29.1 (6.3) years, and median (IQR) length of gestation of 35.0 (7.8) weeks.

Results: About 30% (n=31) of the patients were positive for COVID-19. Most (87.2%) were cesarean deliveries; 4.9% vaginal (8.7% did not deliver). COVID-19, eclampsia/preeclampsia, and postpartum hemorrhage were the most common ICU indications. While the 28-day mortality was 19.3% (n=6) in the COVID-19 group, it was 1.4% (n=1) in the non-COVID-19 group (P<.001). The gestational period was significantly shorter in the COVID-19 group (P=.01) while the duration of stay in ICU (P<.001) and mechanical ventilation (P=.03), lactate (P=.002), blood transfusions (P=.001), plasmapheresis requirements (P=.02), and 28-day mortality were significantly higher (P<.001). APACHE-2 scores (P=.007), duration of stay in ICU (P<.001) and mechanical ventilation (P<.001), RRT (P=.007), and plasmapheresis requirements (P=.005) were significantly higher in patients who died than in those who were discharged.

Conclusion: The most common indication for ICU admission was COVID-19. The APACHE-2 scoring was helpful in predicting mortality. We think multicenter studies with larger sample sizes are needed for COVID-19 obstetric patients. In addition to greater mortality and morbidity, the infection may affect newborn outcomes by causing premature birth.

Limitations: Retrospectıve, single-center, small population size.

Conflict of interest: None.

背景:虽然产科发病率和死亡率最近有所下降,但比率仍然很高,足以构成一个重大的健康问题。随着COVID-19大流行,许多产科患者需要在重症监护病房(ICU)接受治疗。目的:对重症监护病房收治的新冠肺炎产科危重患者进行随访90天的评价。设计:病历回顾设置:Intensıve护理单位PATİENTS和方法:回顾性评估2020年3月15日至2022年3月15日期间入住ICU并随访至少90天的产科患者。比较两组患者的妊娠周数、适应证、合并症、住院时间和ICU时间、机械通气需求、输血、肾替代治疗(RRT)、血浆置换、ICU评分和死亡率。主要结局指标:临床结局和死亡率。样本量和特征:102例患者,平均(SD)年龄29.1(6.3)岁,中位(IQR)妊娠长度35.0(7.8)周。结果:约30% (n=31)患者新冠肺炎阳性。大多数(87.2%)为剖宫产;4.9%阴道分娩(8.7%未分娩)。COVID-19、子痫/先兆子痫和产后出血是ICU最常见的适应症。COVID-19组28天死亡率为19.3% (n=6),非COVID-19组28天死亡率为1.4% (n=1) (PP= 0.01),而死亡患者的ICU住院时间(PP= 0.03)、乳酸(P= 0.002)、输血(P= 0.001)、血浆置换要求(P= 0.02)、28天死亡率(PP= 0.007)、ICU住院时间(PPP= 0.007)、血浆置换要求(P= 0.005)均显著高于出院患者。结论:COVID-19是ICU住院最常见的指征。APACHE-2评分有助于预测死亡率。我们认为需要对COVID-19产科患者进行更大样本量的多中心研究。除了更高的死亡率和发病率外,这种感染还可能通过引起早产来影响新生儿结局。局限性:Retrospectıve,单中心,人口规模小。利益冲突:无。
{"title":"Evaluation of critically ill obstetric patients treated in an intensive care unit during the COVID-19 pandemic.","authors":"Kadir Arslan,&nbsp;Hale Çetin Arslan,&nbsp;Ayca Sultan Şahin","doi":"10.5144/0256-4947.2023.10","DOIUrl":"https://doi.org/10.5144/0256-4947.2023.10","url":null,"abstract":"<p><strong>Background: </strong>Although obstetric morbidity and mortality have decreased recently, rates are still high enough to constitute a significant health problem. With the COVID-19 pandemic, many obstetric patients have required treatment in intensive care units (ICU).</p><p><strong>Objectives: </strong>Evaluate critical obstetric patients who were treated in an ICU for COVID-19 and followed up for 90 days.</p><p><strong>Design: </strong>Medical record review SETTING: Intensıve care unit PATİENTS AND METHODS: Obstetric patients admitted to the ICU between 15 March 2020 and 15 March 2022 and followed up for at least 90 days were evaluated retrospectively. Patients with and without COVID-19 were compared by gestational week, indications, comorbidities, length of stay in the hospital and ICU, requirement for mechanical ventilation, blood transfusion, renal replacement therapy (RRT), plasmapheresis, ICU scores, and mortality.</p><p><strong>Main outcome measures: </strong>Clinical outcomes and mortality.</p><p><strong>Sample size and characteristics: </strong>102 patients with a mean (SD) maternal age of 29.1 (6.3) years, and median (IQR) length of gestation of 35.0 (7.8) weeks.</p><p><strong>Results: </strong>About 30% (n=31) of the patients were positive for COVID-19. Most (87.2%) were cesarean deliveries; 4.9% vaginal (8.7% did not deliver). COVID-19, eclampsia/preeclampsia, and postpartum hemorrhage were the most common ICU indications. While the 28-day mortality was 19.3% (n=6) in the COVID-19 group, it was 1.4% (n=1) in the non-COVID-19 group (<i>P</i><.001). The gestational period was significantly shorter in the COVID-19 group (<i>P</i>=.01) while the duration of stay in ICU (<i>P</i><.001) and mechanical ventilation (<i>P</i>=.03), lactate (<i>P</i>=.002), blood transfusions (<i>P</i>=.001), plasmapheresis requirements (<i>P</i>=.02), and 28-day mortality were significantly higher (<i>P</i><.001). APACHE-2 scores (<i>P</i>=.007), duration of stay in ICU (<i>P</i><.001) and mechanical ventilation (<i>P</i><.001), RRT (<i>P</i>=.007), and plasmapheresis requirements (<i>P</i>=.005) were significantly higher in patients who died than in those who were discharged.</p><p><strong>Conclusion: </strong>The most common indication for ICU admission was COVID-19. The APACHE-2 scoring was helpful in predicting mortality. We think multicenter studies with larger sample sizes are needed for COVID-19 obstetric patients. In addition to greater mortality and morbidity, the infection may affect newborn outcomes by causing premature birth.</p><p><strong>Limitations: </strong>Retrospectıve, single-center, small population size.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"43 1","pages":"10-16"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c2/98/0256-4947.2023.10.PMC9899340.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10792489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comment on: Association between serum vitamin D levels and age in patients with epilepsy: A retrospective study from an epilepsy center in Saudi Arabia. 点评:癫痫患者血清维生素D水平与年龄的关系:沙特阿拉伯癫痫中心的回顾性研究。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-01-01 DOI: 10.5144/0256-4947.2023.62
Mahmood Dhahir Al-Mendalawi
To the Editor: In the July-August 2022 issue of the Annals of Saudi Medicine, Alhaidari et al1 studied the relationship between serum vitamin D (VD) level and age among Saudi patients with epilepsy (PWE) and evaluated factors that might control the seizures. They found a high prevalence of VD deficiency (86.8%). The median serum VD level in the studied cohort was low (38 nmol/L), and was statistically lower in young PWE compared to adult PWE (P<.01). The high serum VD levels were correlated with a 40% seizure reduction.1 Apart from a few study limitations stated by Alhaidari et al,1 we believe that the following limitation is worthy to mention. Several factors could control the cutoff values (CV) of serum VD level. These include age, gender, season, ethnicity, skin color, dietary habits, and sunlight exposure.2 Based on these factors, numerous populations-specific CV of serum VD levels have been formulated to be applied clinically and in research institutions.3,4 Saudi Arabia is among the countries that have generated their CV of serum VD levels and the recommended value for determining VD status and bone health was set at 30.0 nmol/L.5 In the study methodology, Alhaidari et al1 mentioned that serum VD level was grouped into normal (≥75 nmol/L) and low (<75 nmol/L). However, they didn’t state the reference of their utilized CV of serum VD levels. That methodological limitation might importantly query the correctness of the study results. We believe that employing local CV of serum VD level might better fill the objectives of the study by Alhaidari et al.1 Mahmood Dhahir Al-Mendalawi
{"title":"Comment on: Association between serum vitamin D levels and age in patients with epilepsy: A retrospective study from an epilepsy center in Saudi Arabia.","authors":"Mahmood Dhahir Al-Mendalawi","doi":"10.5144/0256-4947.2023.62","DOIUrl":"https://doi.org/10.5144/0256-4947.2023.62","url":null,"abstract":"To the Editor: In the July-August 2022 issue of the Annals of Saudi Medicine, Alhaidari et al1 studied the relationship between serum vitamin D (VD) level and age among Saudi patients with epilepsy (PWE) and evaluated factors that might control the seizures. They found a high prevalence of VD deficiency (86.8%). The median serum VD level in the studied cohort was low (38 nmol/L), and was statistically lower in young PWE compared to adult PWE (P<.01). The high serum VD levels were correlated with a 40% seizure reduction.1 Apart from a few study limitations stated by Alhaidari et al,1 we believe that the following limitation is worthy to mention. Several factors could control the cutoff values (CV) of serum VD level. These include age, gender, season, ethnicity, skin color, dietary habits, and sunlight exposure.2 Based on these factors, numerous populations-specific CV of serum VD levels have been formulated to be applied clinically and in research institutions.3,4 Saudi Arabia is among the countries that have generated their CV of serum VD levels and the recommended value for determining VD status and bone health was set at 30.0 nmol/L.5 In the study methodology, Alhaidari et al1 mentioned that serum VD level was grouped into normal (≥75 nmol/L) and low (<75 nmol/L). However, they didn’t state the reference of their utilized CV of serum VD levels. That methodological limitation might importantly query the correctness of the study results. We believe that employing local CV of serum VD level might better fill the objectives of the study by Alhaidari et al.1 Mahmood Dhahir Al-Mendalawi","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"43 1","pages":"62"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/cc/0256-4947.2023.62.PMC9899338.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9270166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High COX-2 immunostaining in papillary thyroid carcinoma is associated with adverse survival outcomes. 甲状腺乳头状癌高COX-2免疫染色与不良生存结局相关。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-11-01 DOI: 10.5144/0256-4947.2022.359
Jaudah Ahmed Al-Maghrabi, Wafaey Gomaa

Background: Thyroid carcinoma is one of the most common malignancies worldwide. More than 70%-80% are papillary thyroid carcinoma (PTC). Many factors influence the PTC pathway of development such as genetic mutations, growth factors, and radiation. More biological understanding of the genetic and molecular pathways is needed in PTC to determine tumor behavior, and initial clinical assessment.

Objectives: Investigate the relation of COX-2 immunostaining in thyroid carcinoma with clinicopathological parameters to assess whether immunostaining results have prognostic significance.

Design: Retrospective study SETTING: Pathology department, tertiary care center METHODS: Records of PTC were retrieved and tissue microarrays were constructed. Tissue sections were stained using anti-human COX-2 monoclonal antibody. Immunostaining results were recorded and analysed.

Main outcome measures: Relationship of COX-2 immunostaining in thyroid carcinoma with clinicopathological parameters.

Sample size: 139 tissue samples from 139 patients RESULTS: High versus low COX-2 immunostaining showed no significant differences for most clinicopathological parameters. However, high COX-2 immunostaining showed borderline association with tumor multifocality (P=.05), lower overall (log-rank=8.739 and P=.003), and disease-free survival (log-rank=7.033, P=.008).

Conclusion: The study showed a positive association of high COX-2 immunostaining with lower survival outcomes in PTC. COX-2 immunostaining could be a potential prognostic factor for survival in PTC. Additional molecular and clinical investigations are needed for further understanding the molecular pathways of COX-2 in PTC and the feasibility of using inhibitors of COX-2 as adjuvant therapy along with current chemotherapy.

Limitations: Relatively low number of PTC variants, and no testing of other thyroid carcinomas.

Conflict of interest: None.

背景:甲状腺癌是世界上最常见的恶性肿瘤之一。70%-80%为甲状腺乳头状癌(PTC)。许多因素影响PTC的发展途径,如基因突变、生长因子和辐射。在PTC中,需要对遗传和分子途径进行更多的生物学理解,以确定肿瘤行为和初步临床评估。目的:探讨甲状腺癌COX-2免疫染色与临床病理参数的关系,探讨免疫染色结果是否具有预后意义。设计:回顾性研究设置:三级保健中心病理科方法:检索PTC的记录并构建组织芯片。用抗人COX-2单克隆抗体对组织切片进行染色。记录并分析免疫染色结果。主要观察指标:甲状腺癌COX-2免疫染色与临床病理参数的关系。结果:高和低COX-2免疫染色显示大多数临床病理参数无显著差异。然而,高COX-2免疫染色显示与肿瘤多灶性(P= 0.05)、较低的总体(log-rank=8.739和P= 0.003)和无病生存(log-rank=7.033, P= 0.008)呈正相关。结论:研究显示高COX-2免疫染色与PTC患者较低的生存结果呈正相关。COX-2免疫染色可能是PTC患者生存的潜在预后因素。为了进一步了解COX-2在PTC中的分子通路,以及COX-2抑制剂作为辅助治疗与当前化疗的可行性,还需要进一步的分子和临床研究。局限性:PTC变异数量相对较少,未检测到其他甲状腺癌。利益冲突:无。
{"title":"High COX-2 immunostaining in papillary thyroid carcinoma is associated with adverse survival outcomes.","authors":"Jaudah Ahmed Al-Maghrabi,&nbsp;Wafaey Gomaa","doi":"10.5144/0256-4947.2022.359","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.359","url":null,"abstract":"<p><strong>Background: </strong>Thyroid carcinoma is one of the most common malignancies worldwide. More than 70%-80% are papillary thyroid carcinoma (PTC). Many factors influence the PTC pathway of development such as genetic mutations, growth factors, and radiation. More biological understanding of the genetic and molecular pathways is needed in PTC to determine tumor behavior, and initial clinical assessment.</p><p><strong>Objectives: </strong>Investigate the relation of COX-2 immunostaining in thyroid carcinoma with clinicopathological parameters to assess whether immunostaining results have prognostic significance.</p><p><strong>Design: </strong>Retrospective study SETTING: Pathology department, tertiary care center METHODS: Records of PTC were retrieved and tissue microarrays were constructed. Tissue sections were stained using anti-human COX-2 monoclonal antibody. Immunostaining results were recorded and analysed.</p><p><strong>Main outcome measures: </strong>Relationship of COX-2 immunostaining in thyroid carcinoma with clinicopathological parameters.</p><p><strong>Sample size: </strong>139 tissue samples from 139 patients RESULTS: High versus low COX-2 immunostaining showed no significant differences for most clinicopathological parameters. However, high COX-2 immunostaining showed borderline association with tumor multifocality (<i>P</i>=.05), lower overall (log-rank=8.739 and <i>P</i>=.003), and disease-free survival (log-rank=7.033, <i>P</i>=.008).</p><p><strong>Conclusion: </strong>The study showed a positive association of high COX-2 immunostaining with lower survival outcomes in PTC. COX-2 immunostaining could be a potential prognostic factor for survival in PTC. Additional molecular and clinical investigations are needed for further understanding the molecular pathways of COX-2 in PTC and the feasibility of using inhibitors of COX-2 as adjuvant therapy along with current chemotherapy.</p><p><strong>Limitations: </strong>Relatively low number of PTC variants, and no testing of other thyroid carcinomas.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 6","pages":"359-365"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/07/0256-4947.2022.359.PMC9706716.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10403305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical profile, course and outcomes of adults with inflammatory bowel disease over a decade: a single center experience. 十多年来成人炎症性肠病的临床概况、病程和结局:单中心经验
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-11-01 DOI: 10.5144/0256-4947.2022.397
Reham Saleh Aljohani, Ali Alaklabi, Yumna Mohammed Alsitary, Majd Abdulrahman Bin Khunayn, Shahd Omar Hijazi, Rema Ibraheem Alshagary, Rajkumar Rajendram

Background: Inflammatory bowel disease (IBD) is an important cause of morbidity in Saudi Arabia.

Objectives: Determine the incidence, clinical profile, course and outcomes of IBD in Riyadh, Saudi Arabia.

Design: Medical record review SETTING: Tertiary care center PATIENTS AND METHODS: Data were extracted from the medical records of all patients with IBD admitted to King Abdulaziz Medical City, Riyadh, from 1 January 2009 to 31 December 2019. The complications of IBD were classified as gastrointestinal or extraintestinal. Comorbidities were classified as either systemic diseases or gastrointestinal diseases.

Main outcome measures: Epidemiology, clinical manifestations and complications of IBD.

Sample size and characteristics: 435 patients with IBD, median (IQR) age at presentation 24.0 (14.0) years, 242 males (55.6%) RESULTS: The study population consisted of 249 patients with Crohn's disease (CD) (57.2%) and 186 with ulcerative colitis (UC) (42.8%). Nearly half were either overweight or obese. Abdominal pain, diarrhea and vomiting were the most common presenting symptoms. The most common extraintestinal manifestations were musculoskeletal (e.g., arthritis and arthralgia). Colorectal cancer was diagnosed in 3.2%. Patients with other gastrointestinal (GI) comorbidities were at higher risk of developing GI complications of IBD (P≤.05). Biological agents were used to treat 212 patients (87%) with CD and 102 patients (57%) with UC.

Conclusions: The number of patients diagnosed with IBD and their body mass index increased each year over the period of interest. However, the rate of surgical intervention and number of serious complications fell. This improvement in outcomes was associated with a higher percentage of patients receiving biological therapy.

Limitations: Incomplete data. Some patients diagnosed and/or followed up at other hospitals.

Conflict of interest: None.

背景:炎症性肠病(IBD)是沙特阿拉伯发病率的重要原因。目的:确定沙特阿拉伯利雅得IBD的发病率、临床概况、病程和结局。设计:病历审查设置:三级保健中心患者和方法:数据提取自2009年1月1日至2019年12月31日在利雅得阿卜杜勒阿齐兹国王医疗城住院的所有IBD患者的病历。IBD的并发症分为胃肠道和肠外。合并症分为全身性疾病和胃肠道疾病。主要观察指标:IBD的流行病学、临床表现及并发症。样本量和特征:435例IBD患者,就诊时中位(IQR)年龄24.0(14.0)岁,242例男性(55.6%)。结果:研究人群包括249例克罗恩病(CD)患者(57.2%)和186例溃疡性结肠炎(UC)患者(42.8%)。近一半的人超重或肥胖。腹痛、腹泻和呕吐是最常见的症状。最常见的肠外表现是肌肉骨骼(如关节炎和关节痛)。结直肠癌的诊断率为3.2%。合并其他胃肠道合并症的患者发生IBD胃肠道并发症的风险较高(P≤0.05)。生物制剂用于治疗212例(87%)CD患者和102例(57%)UC患者。结论:在研究期间,诊断为IBD的患者数量及其体重指数逐年增加。然而,手术干预率和严重并发症的数量下降。结果的改善与接受生物治疗的患者比例较高有关。局限性:数据不完整。一些患者在其他医院得到诊断和/或随访。利益冲突:无。
{"title":"Clinical profile, course and outcomes of adults with inflammatory bowel disease over a decade: a single center experience.","authors":"Reham Saleh Aljohani,&nbsp;Ali Alaklabi,&nbsp;Yumna Mohammed Alsitary,&nbsp;Majd Abdulrahman Bin Khunayn,&nbsp;Shahd Omar Hijazi,&nbsp;Rema Ibraheem Alshagary,&nbsp;Rajkumar Rajendram","doi":"10.5144/0256-4947.2022.397","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.397","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel disease (IBD) is an important cause of morbidity in Saudi Arabia.</p><p><strong>Objectives: </strong>Determine the incidence, clinical profile, course and outcomes of IBD in Riyadh, Saudi Arabia.</p><p><strong>Design: </strong>Medical record review SETTING: Tertiary care center PATIENTS AND METHODS: Data were extracted from the medical records of all patients with IBD admitted to King Abdulaziz Medical City, Riyadh, from 1 January 2009 to 31 December 2019. The complications of IBD were classified as gastrointestinal or extraintestinal. Comorbidities were classified as either systemic diseases or gastrointestinal diseases.</p><p><strong>Main outcome measures: </strong>Epidemiology, clinical manifestations and complications of IBD.</p><p><strong>Sample size and characteristics: </strong>435 patients with IBD, median (IQR) age at presentation 24.0 (14.0) years, 242 males (55.6%) RESULTS: The study population consisted of 249 patients with Crohn's disease (CD) (57.2%) and 186 with ulcerative colitis (UC) (42.8%). Nearly half were either overweight or obese. Abdominal pain, diarrhea and vomiting were the most common presenting symptoms. The most common extraintestinal manifestations were musculoskeletal (e.g., arthritis and arthralgia). Colorectal cancer was diagnosed in 3.2%. Patients with other gastrointestinal (GI) comorbidities were at higher risk of developing GI complications of IBD (<i>P</i>≤.05). Biological agents were used to treat 212 patients (87%) with CD and 102 patients (57%) with UC.</p><p><strong>Conclusions: </strong>The number of patients diagnosed with IBD and their body mass index increased each year over the period of interest. However, the rate of surgical intervention and number of serious complications fell. This improvement in outcomes was associated with a higher percentage of patients receiving biological therapy.</p><p><strong>Limitations: </strong>Incomplete data. Some patients diagnosed and/or followed up at other hospitals.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 6","pages":"397-407"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/12/0256-4947.2022.397.PMC9706715.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10396946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Assessment of opioid administration patterns following lower extremity fracture among opioid-naïve inpatients: retrospective multicenter cohort study. 阿片类药物无效住院患者下肢骨折后阿片类药物用药模式评估:回顾性多中心队列研究。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-11-01 Epub Date: 2022-12-01 DOI: 10.5144/0256-4947.2022.366
Majed Ramadan, Yahya Alnashri, Amjad Ilyas, Omar Batouk, Khalid A Alsheikh, Laila Alhelabi, Suliman Abdulah Alnashri

Background: Prescribing habits during admission have largely contributed to the opioid epidemic. Orthopedic surgeons represent the third-highest opioid-prescribing specialty. Since more than half of body fractures in Saudi Arabia have been lower extremity fractures, it is imperative to understand opioid administration patterns and correlates among opioid-naïve inpatients.

Objectives: Assess opioid administration patterns and correlates among opioid-naïve inpatients with lower extremity fractures.

Design and settings: Retrospective cohort PATIENTS AND METHODS: Opioid naïve individuals aged 18 to 64 years, admitted due to lower extremity fracture from 2016 to 2020 were included. Data was collected from health records of the Ministry of National Guard Health Affairs (MNG-HA) at five different medical centers. The high-dose (≥50 MME) patients were compared with low dose (<50 MME) patients. Any association between inpatient factors and high-dose opioid use was analyzed by multiple logistic regression.

Main outcome measures: Opioids taken during inpatient admission as measured by milligram morphine equivalents (MME)/per day.

Sample size: 1520 patients RESULTS: Most of the 1520 patients (88.5%) received an opioid medication, while (20.3%) received high-dose opioids at a median daily dose of 33.7 MME/per day. The proportion of patients received naloxone (20.7%) was double among high-dose opioid inpatients. High-dose opioid patients during admission were two times more likely to receive an opioid prescription after discharge (odds ratio, 2.32; 95% confidence interval, 1.53, 3.51), and three more times likely to receive ketamine during admission (odds ratio, 3.02; 95% confidence interval, 1.64, 5.54).

Conclusion: Notable variabilities exist in opioid administration patterns that were not explained by patient factors. Evidence-based opioid prescribing practices should be developed for orthopedic patients to prevent opioid overprescribing and potential opioid overdose among orthopedic patients.

Limitations: Retrospective, unmeasurable confounders might have biased our results. Since based on National Guard employees, results may not be generalizable.

Conflict of interest: None.

背景:入院期间的处方习惯在很大程度上导致了阿片类药物的流行。骨科医生是阿片类药物处方量排名第三的专科。由于沙特阿拉伯半数以上的全身骨折都是下肢骨折,因此了解阿片类药物过敏住院患者的阿片类药物用药模式及相关性势在必行:评估下肢骨折的阿片类药物过敏住院患者的阿片类药物使用模式及相关性:患者和方法:纳入2016年至2020年期间因下肢骨折入院的18至64岁阿片类药物过敏者。数据来自国民警卫队卫生事务部(MNG-HA)在五个不同医疗中心的健康记录。高剂量(≥50 MME)患者与低剂量(主要结果指标:样本量:1520 名患者 结果:1520 名患者中的大多数(88.5%)接受了阿片类药物治疗,而(20.3%)接受了高剂量阿片类药物治疗,每日中位剂量为 33.7 毫克吗啡当量/天。接受纳洛酮治疗的患者比例(20.7%)是大剂量阿片类住院患者的两倍。入院时使用高剂量阿片类药物的患者出院后获得阿片类药物处方的几率是入院时的两倍(几率比,2.32;95% 置信区间,1.53, 3.51),入院时使用氯胺酮的几率是入院时的三倍(几率比,3.02;95% 置信区间,1.64, 5.54):结论:阿片类药物用药模式存在显著差异,而患者因素无法解释这些差异。应为骨科患者制定以证据为基础的阿片类药物处方实践,以防止骨科患者阿片类药物处方过量和潜在的阿片类药物过量:回顾性的、不可测量的混杂因素可能会对我们的结果造成偏差。由于研究对象是国民警卫队雇员,研究结果可能不具有普遍性:无。
{"title":"Assessment of opioid administration patterns following lower extremity fracture among opioid-naïve inpatients: retrospective multicenter cohort study.","authors":"Majed Ramadan, Yahya Alnashri, Amjad Ilyas, Omar Batouk, Khalid A Alsheikh, Laila Alhelabi, Suliman Abdulah Alnashri","doi":"10.5144/0256-4947.2022.366","DOIUrl":"10.5144/0256-4947.2022.366","url":null,"abstract":"<p><strong>Background: </strong>Prescribing habits during admission have largely contributed to the opioid epidemic. Orthopedic surgeons represent the third-highest opioid-prescribing specialty. Since more than half of body fractures in Saudi Arabia have been lower extremity fractures, it is imperative to understand opioid administration patterns and correlates among opioid-naïve inpatients.</p><p><strong>Objectives: </strong>Assess opioid administration patterns and correlates among opioid-naïve inpatients with lower extremity fractures.</p><p><strong>Design and settings: </strong>Retrospective cohort PATIENTS AND METHODS: Opioid naïve individuals aged 18 to 64 years, admitted due to lower extremity fracture from 2016 to 2020 were included. Data was collected from health records of the Ministry of National Guard Health Affairs (MNG-HA) at five different medical centers. The high-dose (≥50 MME) patients were compared with low dose (<50 MME) patients. Any association between inpatient factors and high-dose opioid use was analyzed by multiple logistic regression.</p><p><strong>Main outcome measures: </strong>Opioids taken during inpatient admission as measured by milligram morphine equivalents (MME)/per day.</p><p><strong>Sample size: </strong>1520 patients RESULTS: Most of the 1520 patients (88.5%) received an opioid medication, while (20.3%) received high-dose opioids at a median daily dose of 33.7 MME/per day. The proportion of patients received naloxone (20.7%) was double among high-dose opioid inpatients. High-dose opioid patients during admission were two times more likely to receive an opioid prescription after discharge (odds ratio, 2.32; 95% confidence interval, 1.53, 3.51), and three more times likely to receive ketamine during admission (odds ratio, 3.02; 95% confidence interval, 1.64, 5.54).</p><p><strong>Conclusion: </strong>Notable variabilities exist in opioid administration patterns that were not explained by patient factors. Evidence-based opioid prescribing practices should be developed for orthopedic patients to prevent opioid overprescribing and potential opioid overdose among orthopedic patients.</p><p><strong>Limitations: </strong>Retrospective, unmeasurable confounders might have biased our results. Since based on National Guard employees, results may not be generalizable.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 6","pages":"366-376"},"PeriodicalIF":1.5,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/27/0256-4947.2022.366.PMC9706711.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10403303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transformation of dental services from a governmental model to a revenue-generation model of operation in a tertiary care hospital: a health economics assessment. 三级保健医院牙科服务从政府模式转变为创收模式:卫生经济学评估。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-11-01 DOI: 10.5144/0256-4947.2022.351
Rajaa Alsanea, Wadood Mohammednour Tawfiq, Osama Abdulrahman Alswailem, Tariq Alali, Abdullah Rashid AlBarkheel

Background: Healthcare in Saudi Arabia is under transformation from a national free health service to a system paid either by insurance or governmental funds. This change will impact the model of operation including dental services.

Objectives: Estimate the revenue of the Department of Dentistry based on an insurance-based billing system.

Design: Medical record review SETTING: An academic tertiary care hospital in Riyadh PATIENT AND METHODS: Data on outpatient visits for the period 2015-2019 was extracted from the electronic health records. The billing data was categorized by specialty and current procedure terminology (CPT) code. The revenue stream for each CPT code was estimated and compared between the actual cost of service for each CPT code billed price, and average price of the market leaders in private practice.

Main outcome measure: Revenue generated by the department.

Sample: 339 421 outpatient visits for 22 056 patients.

Results: Female and males made 179 555 (52.9%) and 159 858 (47.1%) outpatient visits, respectively. Outpatient divided by the age groups: ≤14,15-65, >65 years were 58 868 (17.3%), 251 552 (74.1%), 29 001 (8.5%), respectively. The visits divided by specialty were as follows: general dentistry 28.1%, pedodontics 12.5%, orthodontics 7.1%, endodontics 7.0%, oral and maxillofacial surgery 6.9%, prosthodontics 4.4% and periodontics 3.3%. Outpatient visits to the nursing clinic and hygienist amounted to 30.7%. The median number of visits per patient per year was 5 (range, 1-63), which increased to 6 (range, 1-110) in 2019. The annual revenue plateaued in 2019 at 13 983 538 SAR (3 728 943 USD) with only a 2.2% of increase from 2018. Out of 292 CPT codes, 44.8% were priced below the actual cost. Moreover, 28.4% showed pricing below actual cost, but higher than the price of the market leaders. There was an annual loss of revenue of 10.1% due to incorrect pricing of CPT codes. Average productivity of the dentist and hygienist amounted to 2263 and 760 visits per year, respectively.

Conclusions: There is a need for improvement in delivery of care, cost-containment, productivity and amendment of charge description master pricing.

Limitations: The sample did not include data from the period 2020-2022 due to the restriction of dental services due to the COVID-19 epidemic.

Conflict of interest: None.

背景:沙特阿拉伯的医疗保健正在从国家免费医疗服务转变为由保险或政府基金支付的系统。这一变化将影响包括牙科服务在内的运作模式。目的:估算基于保险计费系统的牙科部门的收入。设计:病历审查环境:利雅得的一家三级医院患者和方法:从电子健康记录中提取2015-2019年期间的门诊就诊数据。账单数据按专业和当前过程术语(CPT)代码分类。对每个CPT代码的收入流进行了估计,并将每个CPT代码的实际服务成本与私人实践中市场领导者的平均价格进行了比较。主要衡量指标:部门产生的收入。样本:339421门诊人次,22 056例患者。结果:女性179 555人次(52.9%),男性159 858人次(47.1%)。按年龄划分:≤14岁、15 ~ 65岁、>65岁分别为58 868人(17.3%)、251 552人(74.1%)、29 001人(8.5%)。按专科划分,普通牙科28.1%、儿科学12.5%、正畸学7.1%、牙髓学7.0%、口腔颌面外科6.9%、口腔修复学4.4%、牙周病3.3%。到护理诊所和卫生员门诊就诊的占30.7%。每位患者每年就诊的中位数为5次(范围1-63次),2019年增加到6次(范围1-110次)。2019年的年收入稳定在13 983 538里亚尔(3 728 943美元),仅比2018年增长2.2%。在292个CPT代码中,44.8%的价格低于实际成本。此外,28.4%的企业定价低于实际成本,但高于市场领先企业的价格。由于不正确的CPT代码定价,每年的收入损失为10.1%。牙医和保健师每年的平均诊治次数分别为2263次和760次。结论:需要在提供护理、成本控制、生产力和修改收费说明主定价方面进行改进。局限性:由于COVID-19流行限制了牙科服务,该样本未包括2020-2022年期间的数据。利益冲突:无。
{"title":"Transformation of dental services from a governmental model to a revenue-generation model of operation in a tertiary care hospital: a health economics assessment.","authors":"Rajaa Alsanea,&nbsp;Wadood Mohammednour Tawfiq,&nbsp;Osama Abdulrahman Alswailem,&nbsp;Tariq Alali,&nbsp;Abdullah Rashid AlBarkheel","doi":"10.5144/0256-4947.2022.351","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.351","url":null,"abstract":"<p><strong>Background: </strong>Healthcare in Saudi Arabia is under transformation from a national free health service to a system paid either by insurance or governmental funds. This change will impact the model of operation including dental services.</p><p><strong>Objectives: </strong>Estimate the revenue of the Department of Dentistry based on an insurance-based billing system.</p><p><strong>Design: </strong>Medical record review SETTING: An academic tertiary care hospital in Riyadh PATIENT AND METHODS: Data on outpatient visits for the period 2015-2019 was extracted from the electronic health records. The billing data was categorized by specialty and current procedure terminology (CPT) code. The revenue stream for each CPT code was estimated and compared between the actual cost of service for each CPT code billed price, and average price of the market leaders in private practice.</p><p><strong>Main outcome measure: </strong>Revenue generated by the department.</p><p><strong>Sample: </strong>339 421 outpatient visits for 22 056 patients.</p><p><strong>Results: </strong>Female and males made 179 555 (52.9%) and 159 858 (47.1%) outpatient visits, respectively. Outpatient divided by the age groups: ≤14,15-65, >65 years were 58 868 (17.3%), 251 552 (74.1%), 29 001 (8.5%), respectively. The visits divided by specialty were as follows: general dentistry 28.1%, pedodontics 12.5%, orthodontics 7.1%, endodontics 7.0%, oral and maxillofacial surgery 6.9%, prosthodontics 4.4% and periodontics 3.3%. Outpatient visits to the nursing clinic and hygienist amounted to 30.7%. The median number of visits per patient per year was 5 (range, 1-63), which increased to 6 (range, 1-110) in 2019. The annual revenue plateaued in 2019 at 13 983 538 SAR (3 728 943 USD) with only a 2.2% of increase from 2018. Out of 292 CPT codes, 44.8% were priced below the actual cost. Moreover, 28.4% showed pricing below actual cost, but higher than the price of the market leaders. There was an annual loss of revenue of 10.1% due to incorrect pricing of CPT codes. Average productivity of the dentist and hygienist amounted to 2263 and 760 visits per year, respectively.</p><p><strong>Conclusions: </strong>There is a need for improvement in delivery of care, cost-containment, productivity and amendment of charge description master pricing.</p><p><strong>Limitations: </strong>The sample did not include data from the period 2020-2022 due to the restriction of dental services due to the COVID-19 epidemic.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 6","pages":"351-358"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bd/f9/0256-4947.2022.351.PMC9706714.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10403308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of strabismus and visual outcomes in children with hydrocephalus and a ventriculoperitoneal shunt: medical record review. 脑积水合并脑室-腹膜分流的儿童斜视患病率和视力结局:医疗记录回顾
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-11-01 DOI: 10.5144/0256-4947.2022.391
Saif Saleh AlObaisi, Bashair Nasser Alnasser, Hana Abdulaziz Almuhawas, Saja Abdulrahmn Alhoshan, Modhi Abdullah Alamer, Rana Mohammad Alshaye, Sulaiman Abdulaziz Aldakhil, Manal Mosaad Alabdulmunem

Background: Many ophthalmological complications have been associated with hydrocephalus (HC), including ocular motility disorders, visual field defects, optic atrophy, and loss of visual acuity. No studies have investigated the prevalence of strabismus and visual outcomes of children with congenital HC after ventriculoperitoneal (VP) shunt in Saudi Arabia.

Objectives: Estimate the frequency of strabismic children diagnosed with HC who underwent a VP shunt procedure.

Design: Medical record review SETTING: Tertiary care center PATIENTS AND METHODS: We reviewed the files of all pediatric patients diagnosed with hydrocephalus before the age of 2 years and treated with shunts during the period 2010 to 2020 at our institution.

Main outcome measures: Strabismus types and ophthalmic assessment (visual state, outcomes, and ocular motility state).

Sample size and characteristics: 190 children; 98 (51.5%) males.

Results: Eighty-nine (46.8%) had congenital HC followed by intraventricular hemorrhage 36 (18.9%); 74 (38.9%) patients had regular follow-ups in ophthalmology. Sixty-five (34.2%) patients had no ophthalmic assessment or fundus examination records, while 63 (33.1%) were diagnosed with strabismus. At the initial assessment, 26 (13.6%) patients had exotropia (XT). At the final assessment, 7 (3.6%) patients had XT. The association between VP shunt and strabismus was statistically significant, (χ2=6.534, df=1, P<.01).

Conclusion: More than one-third of children diagnosed with HC who had surgical treatment in a tertiary hospital did not have any records of ophthalmic assessment, which highlights the need to implement a specific ophthalmological examination protocol in patients with HC. Further studies are needed to analyze the association between VP shunt and strabismus.

Limitations: Evaluating the ocular state and visual function before and after VP shunt was not possible.

Conflict of interest: None.

背景:许多眼科并发症与脑积水(HC)有关,包括眼球运动障碍、视野缺损、视神经萎缩和视力丧失。在沙特阿拉伯,没有研究调查先天性HC患儿脑室-腹膜(VP)分流术后斜视的患病率和视力结果。目的:估计诊断为HC的斜视儿童接受VP分流手术的频率。设计:病历回顾设置:三级保健中心患者和方法:我们回顾了2010年至2020年期间在本机构诊断为2岁以下脑积水并接受分流治疗的所有儿童患者的档案。主要结果测量:斜视类型和眼科评估(视觉状态、结果和眼运动状态)。样本量及特征:190名儿童;男性98人(51.5%)。结果:先天性HC 89例(46.8%)合并脑室内出血36例(18.9%);74例(38.9%)患者定期眼科随访。65例(34.2%)无眼科检查或眼底检查记录,63例(33.1%)诊断为斜视。初步评估时,26例(13.6%)患者有外斜视(XT)。最终评估时,7例(3.6%)患者有XT。VP分流术与斜视的相关性有统计学意义(χ2=6.534, df=1, p)。结论:在三级医院接受手术治疗的HC患儿中,超过三分之一的患者没有任何眼科检查记录,因此需要对HC患者实施专门的眼科检查方案。需要进一步的研究来分析VP分流与斜视的关系。局限性:不可能评估VP分流前后的眼状态和视觉功能。利益冲突:无。
{"title":"The prevalence of strabismus and visual outcomes in children with hydrocephalus and a ventriculoperitoneal shunt: medical record review.","authors":"Saif Saleh AlObaisi,&nbsp;Bashair Nasser Alnasser,&nbsp;Hana Abdulaziz Almuhawas,&nbsp;Saja Abdulrahmn Alhoshan,&nbsp;Modhi Abdullah Alamer,&nbsp;Rana Mohammad Alshaye,&nbsp;Sulaiman Abdulaziz Aldakhil,&nbsp;Manal Mosaad Alabdulmunem","doi":"10.5144/0256-4947.2022.391","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.391","url":null,"abstract":"<p><strong>Background: </strong>Many ophthalmological complications have been associated with hydrocephalus (HC), including ocular motility disorders, visual field defects, optic atrophy, and loss of visual acuity. No studies have investigated the prevalence of strabismus and visual outcomes of children with congenital HC after ventriculoperitoneal (VP) shunt in Saudi Arabia.</p><p><strong>Objectives: </strong>Estimate the frequency of strabismic children diagnosed with HC who underwent a VP shunt procedure.</p><p><strong>Design: </strong>Medical record review SETTING: Tertiary care center PATIENTS AND METHODS: We reviewed the files of all pediatric patients diagnosed with hydrocephalus before the age of 2 years and treated with shunts during the period 2010 to 2020 at our institution.</p><p><strong>Main outcome measures: </strong>Strabismus types and ophthalmic assessment (visual state, outcomes, and ocular motility state).</p><p><strong>Sample size and characteristics: </strong>190 children; 98 (51.5%) males.</p><p><strong>Results: </strong>Eighty-nine (46.8%) had congenital HC followed by intraventricular hemorrhage 36 (18.9%); 74 (38.9%) patients had regular follow-ups in ophthalmology. Sixty-five (34.2%) patients had no ophthalmic assessment or fundus examination records, while 63 (33.1%) were diagnosed with strabismus. At the initial assessment, 26 (13.6%) patients had exotropia (XT). At the final assessment, 7 (3.6%) patients had XT. The association between VP shunt and strabismus was statistically significant, (χ<sup>2</sup>=6.534, df=1, <i>P</i><.01).</p><p><strong>Conclusion: </strong>More than one-third of children diagnosed with HC who had surgical treatment in a tertiary hospital did not have any records of ophthalmic assessment, which highlights the need to implement a specific ophthalmological examination protocol in patients with HC. Further studies are needed to analyze the association between VP shunt and strabismus.</p><p><strong>Limitations: </strong>Evaluating the ocular state and visual function before and after VP shunt was not possible.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 6","pages":"391-396"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/e2/0256-4947.2022.391.PMC9706712.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10396949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Accuracy of conventional disease severity scores in predicting COVID-19 ICU mortality: retrospective single-center study in Turkey. 传统疾病严重程度评分预测COVID-19 ICU死亡率的准确性:土耳其回顾性单中心研究
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-11-01 DOI: 10.5144/0256-4947.2022.408
Suleyman Yildrim, Cenk Kirakli

Background: Disease severity scores are important tools for predicting mortality in intensive care units (ICUs), but conventional disease severity scores may not be suitable for predicting mortality in coronavirus disease-19 (COVID-19) patients.

Objective: Compare conventional disease severity scores for discriminative power in ICU mortality.

Design: Retrospective cohort SETTING: Intensive care unit in tertiary teaching and research hospital.

Patients and methods: COVID-19 patients who were admitted to our ICU between 11 March 2020 and 31 December 2021 were included in the study. Patients who died within the first 24 hours were not included. SAPS II, APACHE II and APACHE 4 scores were calculated within the first 24 hours of ICU admission. A receiver operating characteristics (ROC) analysis was performed for discriminative power of disease severity scores.

Main outcome measure: ICU mortality SAMPLE SIZE AND CHARACTERISTICS: 510 subjects with median (interquartile percentiles) age of 65 (56-74) years.

Results: About half (n=250, 51%) died during ICU stay. Three disease severity scores had similar discriminative power, the area under the curve (AUC), SAPS II (AUC 0.79), APACHE II (AUC 0.76), APACHE 4 (AUC 0.78) (P<.001). Observed mortality was higher than predicted mortality according to conventional disease severity scores.

Conclusion: Conventional disease severity scores are good indicators of COVID-19 severity. However, they may underestimate mortality in COVID-19. New scoring systems should be developed for mortality prediction in COVID-19.

Limitation: A single-center study CONFLICT OF INTEREST: None.

背景:疾病严重程度评分是预测重症监护病房(icu)死亡率的重要工具,但传统的疾病严重程度评分可能不适合预测冠状病毒病-19 (COVID-19)患者的死亡率。目的:比较传统疾病严重程度评分对ICU死亡率的判别能力。设计:回顾性队列设置:高等教学研究型医院重症监护室。患者和方法:研究纳入了2020年3月11日至2021年12月31日期间入住我们ICU的COVID-19患者。在最初24小时内死亡的患者不包括在内。在ICU入院前24小时内计算SAPS II、APACHE II和APACHE 4评分。采用受试者工作特征(ROC)分析疾病严重程度评分的判别能力。主要结局指标:ICU死亡率。样本量和特征:510名受试者,中位(四分位数)年龄为65(56-74)岁。结果:约半数(n=250, 51%)患者在ICU期间死亡。3种疾病严重程度评分具有相似的判别能力,曲线下面积(AUC)、SAPSⅱ(AUC 0.79)、APACHEⅱ(AUC 0.76)、APACHE 4 (AUC 0.78)(结论:常规疾病严重程度评分是衡量新冠肺炎严重程度的良好指标。然而,他们可能低估了COVID-19的死亡率。应开发新的评分系统来预测COVID-19的死亡率。局限性:单中心研究。利益冲突:无。
{"title":"Accuracy of conventional disease severity scores in predicting COVID-19 ICU mortality: retrospective single-center study in Turkey.","authors":"Suleyman Yildrim,&nbsp;Cenk Kirakli","doi":"10.5144/0256-4947.2022.408","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.408","url":null,"abstract":"<p><strong>Background: </strong>Disease severity scores are important tools for predicting mortality in intensive care units (ICUs), but conventional disease severity scores may not be suitable for predicting mortality in coronavirus disease-19 (COVID-19) patients.</p><p><strong>Objective: </strong>Compare conventional disease severity scores for discriminative power in ICU mortality.</p><p><strong>Design: </strong>Retrospective cohort SETTING: Intensive care unit in tertiary teaching and research hospital.</p><p><strong>Patients and methods: </strong>COVID-19 patients who were admitted to our ICU between 11 March 2020 and 31 December 2021 were included in the study. Patients who died within the first 24 hours were not included. SAPS II, APACHE II and APACHE 4 scores were calculated within the first 24 hours of ICU admission. A receiver operating characteristics (ROC) analysis was performed for discriminative power of disease severity scores.</p><p><strong>Main outcome measure: </strong>ICU mortality SAMPLE SIZE AND CHARACTERISTICS: 510 subjects with median (interquartile percentiles) age of 65 (56-74) years.</p><p><strong>Results: </strong>About half (n=250, 51%) died during ICU stay. Three disease severity scores had similar discriminative power, the area under the curve (AUC), SAPS II (AUC 0.79), APACHE II (AUC 0.76), APACHE 4 (AUC 0.78) (<i>P</i><.001). Observed mortality was higher than predicted mortality according to conventional disease severity scores.</p><p><strong>Conclusion: </strong>Conventional disease severity scores are good indicators of COVID-19 severity. However, they may underestimate mortality in COVID-19. New scoring systems should be developed for mortality prediction in COVID-19.</p><p><strong>Limitation: </strong>A single-center study CONFLICT OF INTEREST: None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 6","pages":"408-414"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/b2/0256-4947.2022.408.PMC9706719.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10396947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pattern of chromosomal abnormalities in recurrent miscarriages: a single center retrospective study. 复发性流产的染色体异常模式:一项单中心回顾性研究。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-11-01 DOI: 10.5144/0256-4947.2022.385
Ayca Kocaaga, Halime Kilic, Sevgi Gulec

Background: Chromosomal abnormalities are more common in first trimester recurrent miscarriages (RM). Chromosomal anomalies affect approximately 2%-8% of couples with RM.

Objectives: Evaluate the spectrum and the frequencies of chromosomal anomalies in RM.

Design: A retrospective hospital record-based descriptive study.

Setting: A tertiary care center in Turkey.

Patients and methods: We studied couples with RM between October 2020 and January 2022. Relevant family and medical history, clinical examination and the results of karyotype were statistically analyzed.

Main outcome measures: Prevalence and types of chromosomal aberrations in couples with RM. SAMPLE SİZE: 362 couples with a history of RM RESULTS: Among the 362 couples, 14 cases (3.86%) had chromosome abnormalities. Eight cases (57.14%) were structural anomalies and six cases (42.86%) were numerical chromosomal aberrations. We found five balanced translocations (67.5%) and three Robertsonian translocations (37.5%). The prevalence of polymorphic variants was 51/362 (14.1%).

Conclusions: This study supports the conclusion that clinicians should understand the importance of chromosome analysis in these couples and direct them to karyotyping after two abortions in order to exclude the possibility of a genetic cause of RM.

Limitations: Single-center study and retrospective.

Conflict of interest: None.

背景:染色体异常在妊娠早期复发性流产(RM)中更为常见。染色体异常影响约2%-8%的RM夫妇。目的:评价RM染色体异常的谱和频率。设计:一项基于医院记录的回顾性描述性研究。环境:土耳其的一个三级保健中心。患者和方法:我们研究了2020年10月至2022年1月期间患有RM的夫妇。对相关家族史、病史、临床检查及核型结果进行统计学分析。主要观察指标:RM夫妇中染色体畸变的发生率和类型。样本SİZE: 362对有RM病史的夫妇结果:362对夫妇中,染色体异常14例(3.86%)。结构异常8例(57.14%),数字染色体畸变6例(42.86%)。发现5个平衡易位(67.5%)和3个罗伯逊易位(37.5%)。多态性变异发生率为51/362(14.1%)。结论:本研究支持这样的结论:临床医生应该了解染色体分析对这些夫妇的重要性,并指导他们在两次流产后进行核型分析,以排除RM遗传原因的可能性。局限性:单中心研究和回顾性研究。利益冲突:无。
{"title":"The pattern of chromosomal abnormalities in recurrent miscarriages: a single center retrospective study.","authors":"Ayca Kocaaga,&nbsp;Halime Kilic,&nbsp;Sevgi Gulec","doi":"10.5144/0256-4947.2022.385","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.385","url":null,"abstract":"<p><strong>Background: </strong>Chromosomal abnormalities are more common in first trimester recurrent miscarriages (RM). Chromosomal anomalies affect approximately 2%-8% of couples with RM.</p><p><strong>Objectives: </strong>Evaluate the spectrum and the frequencies of chromosomal anomalies in RM.</p><p><strong>Design: </strong>A retrospective hospital record-based descriptive study.</p><p><strong>Setting: </strong>A tertiary care center in Turkey.</p><p><strong>Patients and methods: </strong>We studied couples with RM between October 2020 and January 2022. Relevant family and medical history, clinical examination and the results of karyotype were statistically analyzed.</p><p><strong>Main outcome measures: </strong>Prevalence and types of chromosomal aberrations in couples with RM. SAMPLE SİZE: 362 couples with a history of RM RESULTS: Among the 362 couples, 14 cases (3.86%) had chromosome abnormalities. Eight cases (57.14%) were structural anomalies and six cases (42.86%) were numerical chromosomal aberrations. We found five balanced translocations (67.5%) and three Robertsonian translocations (37.5%). The prevalence of polymorphic variants was 51/362 (14.1%).</p><p><strong>Conclusions: </strong>This study supports the conclusion that clinicians should understand the importance of chromosome analysis in these couples and direct them to karyotyping after two abortions in order to exclude the possibility of a genetic cause of RM.</p><p><strong>Limitations: </strong>Single-center study and retrospective.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 6","pages":"385-390"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/11/0256-4947.2022.385.PMC9706713.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10403306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Annals of Saudi Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1